Drug intelligence / Profile preview

bupivacaine + carbopol hydrogel

Development stage
Unknown
Modality
Small Molecules, Hydrogel Systems → Drug Delivery Systems
Administration
Local
01

Overview

Bupivacaine + carbopol hydrogel is an investigational sustained-release formulation of the local anesthetic bupivacaine. It utilizes a carbopol-based hydrogel (such as Carbopol 934) as a biodegradable and biocompatible delivery system to provide localized analgesia. By entrapping bupivacaine within the cross-linked polymer matrix, the formulation aims to prolong the duration of pain relief and reduce the need for systemic analgesics, including opioids, following surgical procedures. It has been specifically evaluated in clinical trials for postoperative pain management after mandibular third molar extractions.

Other names
Bupivacaine/Carbopol hydrogeldegradable Bupivacaine/Carbopol hydrogel
02

Targets

PTGER1 (Prostaglandin E Receptor 1)SCN5A (Sodium channel protein type 5 subunit alpha)Nav1.1–Nav1.6 (Voltage-gated sodium channel alpha subunits 1.1 through 1.6)SCN9A (Sodium channel protein type 9 subunit alpha)

Beyond the preview

Go deeper on bupivacaine + carbopol hydrogel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine + carbopol hydrogel.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call